Resonium-Calcium 1 g/ g Norge - norsk - Statens legemiddelverk

resonium-calcium 1 g/ g

sanofi-aventis norge (3) - kalsiumpolystyrensulfonat - pulver til mikstur/rektalvæske, suspensjon - 1 g/ g

Solvivo 0.6 mg / 1.2 mg Norge - norsk - Statens legemiddelverk

solvivo 0.6 mg / 1.2 mg

geiser pharma s.l. - amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med mintsmak - 0.6 mg / 1.2 mg

Solvivo 0.6 mg / 1.2 mg Norge - norsk - Statens legemiddelverk

solvivo 0.6 mg / 1.2 mg

geiser pharma s.l. - amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med honning- og sitronsmak - 0.6 mg / 1.2 mg

TRESOLIN WP Norge - norsk - Ecolab

tresolin wp

ecolab deutschland gmbh -

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med honning- og sitronsmak - 2 mg / 0.6 mg / 1.2 mg

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med appelsinsmak - 2 mg / 0.6 mg / 1.2 mg

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med mintsmak - 2 mg / 0.6 mg / 1.2 mg

Topotecan Ebewe 1 mg/ ml Norge - norsk - Statens legemiddelverk

topotecan ebewe 1 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - topotekanhydroklorid - konsentrat til infusjonsvæske, oppløsning - 1 mg/ ml

Blincyto Den europeiske union - norsk - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Diflucan 100 mg Norge - norsk - Statens legemiddelverk

diflucan 100 mg

pfizer as - flukonazol - kapsel, hard - 100 mg